Navigation Links
TorreyPines Therapeutics Announces Strategic Plan with Focus on Clinical Development Activities to Maximize Value of Versatile Lead Compounds
Date:2/14/2008

- Plan Also Calls for Expansion of Business Development, Streamlining of

Operations -

- Company to Host Conference Call/Webcast at 11 a.m. EST Today -

LA JOLLA, Calif., Feb. 14 /PRNewswire/ -- TorreyPines Therapeutics, Inc. (Nasdaq: TPTX) today announced a strategic plan for 2008 with a focus on clinical development activities to maximize the value of the company's versatile lead compounds: AMPA/kainate receptor antagonists tezampanel and NGX426 and muscarinic agonist NGX267. The plan also calls for the expansion of business development initiatives to evaluate partnership opportunities across the company's product pipeline and the streamlining of operations through an expense-reduction program.

Specifically, the company intends to:

Maximize Value of Versatile Lead Compounds

AMPA/kainate receptor antagonists

-- Conduct a Clinical Guidance meeting with the U.S. Food and Drug

Administration (FDA) in the first half of the year to discuss the

efficacy results from the recently completed Phase II clinical

trial of tezampanel in acute migraine headache. As reported last

October, tezampanel met its primary endpoint of headache pain

relief in a double-blind, placebo-controlled, Phase IIb trial in

306 patients with acute migraine. Depending on the outcome of the

meeting, the company intends to conduct an end-of-Phase II meeting

with the FDA in the second half of 2008.

-- Initiate a Phase II trial of tezampanel in muscle spasticity and

rigidity secondary to spinal cord trauma in the second half of the

year. This trial will b
'/>"/>

SOURCE TorreyPines Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Multiple Dose Clinical Trial of TorreyPines Therapeutics Tezampanel Demonstrates Compound is Safe and Well-Tolerated
2. Pharmacokinetic Data Suggest NGX426, TorreyPines Therapeutics Oral Prodrug of Tezampanel, May be Effective in Treating Acute Migraine Headache
3. Tezampanel, TorreyPines Therapeutics Lead Compound, Reduced Muscle Spasticity and Rigidity in Preclinical Study Conducted at University of California, San Diego
4. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
5. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
6. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
7. Horizon Therapeutics Completes Enrollment in Phase 3 Trials for Lead Product Candidate HZT-501
8. PTC Therapeutics Announces Publication of Preclinical Data in PNAS
9. ImaRx Therapeutics Transitions Business Strategy
10. Protalix BioTherapeutics Extends Research Agreement With Yissum Based on Promising Acetylcholinesterase Program Results in Animal Study
11. Fundamental Applied Biology, Inc. Is Awarded SBIR Phase IIB Grant for the Commercialization of Protein Therapeutics Using Cell Free Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... CardioVascular Institute enrolled the first patient in Pennsylvania ... in a trial assessing the safety and effectiveness ... main artery of the leg. The new stent allows for ... stent fracture or re-narrowing after the stent is placed. ... the BioMimics 3D Stent System and will enroll 280 subjects ...
(Date:8/27/2015)...  Lightwave Logic, Inc. (OTCQB: LWLG), a technology ... Generation Photonic Devices and Non-Linear Optical Polymer Materials ... data communications and optical computing, announced today that ... to the Company,s Board of Directors. ... is widely recognized with wide-ranging experience across many ...
(Date:8/27/2015)... SAN FRANCISCO, Calif. , Aug. 27, 2015 ... Probody™ therapeutics for the treatment of cancer, today ... a member of the company,s Board of Directors, ... formerly led immuno-oncology at Eli Lilly and AstraZeneca, ... the first FDA approved checkpoint inhibitor, at Bristol-Myers ...
Breaking Medicine Technology:First Pennsylvania Patient Treated in Landmark Vascular Study 2Lightwave Logic Announces the Appointment of Optoelectronics Industry Leader, Michael Lebby, Ph.D. to its Board of Directors 2Lightwave Logic Announces the Appointment of Optoelectronics Industry Leader, Michael Lebby, Ph.D. to its Board of Directors 3Immuno-Oncology Veteran Rachel Humphrey, M.D., Joins CytomX as Chief Medical Officer 2Immuno-Oncology Veteran Rachel Humphrey, M.D., Joins CytomX as Chief Medical Officer 3
... May 7, 2012  AssureRx Health, Inc. today announced ... the growing number of children and adults diagnosed ... pharmacogenomic test can assist clinicians with important medication ... individual patients tolerate ADHD medications. ...
...  BioElectronics Corporation (OTC-PINK: BIEL), the maker of disposable, ... announced the completion of a randomized, controlled trial ... product.  ActiPatch uses pulsed electromagnetic field therapy to ... injured tissue. A double blind, ...
Cached Medicine Technology:AssureRx Health Launches Personalized Medicine Test for ADHD 2AssureRx Health Launches Personalized Medicine Test for ADHD 3BioElectronics' ActiPatch Reduces Muscle Soreness in Runners 2
(Date:8/27/2015)... ... August 27, 2015 , ... Healthpointe is proud to welcome Dr. Ted Priebe, ... Angeles. Licensed to practice Chinese Needle Therapy since 1983, Dr. Priebe specializes in the ... Priebe also practices in Healthpointe’s La Mirada clinic and Garden Grove clinic. , ...
(Date:8/27/2015)... ... August 27, 2015 , ... More destinations and stores ... trip. That’s why Amica Insurance is sharing some tips to help your whole family ... 30 million people travel with pets each year. Amica is sharing the following tips ...
(Date:8/27/2015)... ... 27, 2015 , ... Banc Intranets recently entered into a strategic ... both Johnson City, Tenn.-based firms to work synergistically to promote similar products to the ... caters to organizations in the financial, commercial and services sectors. The software, which is ...
(Date:8/27/2015)... ... 2015 , ... For the first time, Ninja® introduces Nutrient ... Ninja® Auto-iQ Pro Complete and Nutri Ninja Auto-iQ Compact System. These two exciting ... to a whole new level. This line of Nutri Ninja products is designed ...
(Date:8/27/2015)... (PRWEB) , ... August 27, 2015 , ... Florida Hospital North Pinellas, located at 1395 ... in the Fall of 2016. The new facility will be located at US Highway 19 ... The property closed on August 18, and work on the project is slated to begin ...
Breaking Medicine News(10 mins):Health News:Qualified Medical Examiner and Acupuncturist Joins Healthpointe in Los Angeles 2Health News:Qualified Medical Examiner and Acupuncturist Joins Healthpointe in Los Angeles 3Health News:Amica Unleashes 5 Tips for Safe Traveling with Pets 2Health News:Banc Intranets Forms Strategic Marketing Partnership with All Clear System 2Health News:Banc Intranets Forms Strategic Marketing Partnership with All Clear System 3Health News:Banc Intranets Forms Strategic Marketing Partnership with All Clear System 4Health News:SharkNinja's Nutri Ninja® Auto-iQ™ Pro Complete Delivers Power And Versatility In A Compact Design 2Health News:SharkNinja's Nutri Ninja® Auto-iQ™ Pro Complete Delivers Power And Versatility In A Compact Design 3Health News:SharkNinja's Nutri Ninja® Auto-iQ™ Pro Complete Delivers Power And Versatility In A Compact Design 4Health News:Florida Hospital North Pinellas is Opening a New Free-Standing Emergency Room in Palm Harbor 2Health News:Florida Hospital North Pinellas is Opening a New Free-Standing Emergency Room in Palm Harbor 3
... 29 Jean-Yves Naouri, Executive,Vice President (Group Operations) ... been appointed to oversee Publicis Healthcare,Communications Group (PHCG) ... and CEO of Publicis Groupe, declared: "PHCG has,built ... Nick,Colucci, CEO, and his teams are doing an ...
... Lisa Sandler Spaeth as an active mother of two ... juggling her son,s baseball games and her daughter,s horseback-riding ... her local synagogue. Add to this Spaeth,s thriving ... accessories for children - which she founded with her ...
... Burgess(TM) a leading,Medicare-based data and information technology ... its Woodland Hills, California based,client, Health Net., ... managed health care company, employing,approximately 10,000 associates ... subsidiaries provide health benefits to over 6 ...
... July 29 MD On-Line, a leading,healthcare ... between providers and payers, announced today that ... Rules for Information Exchange (CORE(TM)),Clearinghouse Certification Seal. ... successfully completed Phase I certification testing -- ...
... Issue Despite Experiencing Leg Pain and ... ... the legs -- force many embarrassed sufferers to cover up, even on,the ... can develop into serious health problems. According,to a new survey, many who ...
... on Local Seniors to Receive Extensive Publicity,Discussion if Medicare ... The Coalition to Protect,Senior Care today stated stopping the ... which will cut $770 million in U.S.,seniors, Medicare Part ... priority for 2008, and said the negative,impact on local ...
Cached Medicine News:Health News:Jean-Yves Naouri to Oversee Publicis Healthcare Communications Group (PHCG) 2Health News:Jean-Yves Naouri to Oversee Publicis Healthcare Communications Group (PHCG) 3Health News:Note to people with scarred and stiffened lungs: Monitor your sleep before severe fatigue sets in 2Health News:Note to people with scarred and stiffened lungs: Monitor your sleep before severe fatigue sets in 3Health News:Note to people with scarred and stiffened lungs: Monitor your sleep before severe fatigue sets in 4Health News:Burgess Announces Expanded Software Partnership With Health Net 2Health News:MD On-Line Achieves CAQH CORE(TM) Certification for Consistent Healthcare Administrative Data Exchange 2Health News:MD On-Line Achieves CAQH CORE(TM) Certification for Consistent Healthcare Administrative Data Exchange 3Health News:Survey Shows People With Varicose Veins Unaware of Health Risks; Most Never Consider Treatment 2Health News:Survey Shows People With Varicose Veins Unaware of Health Risks; Most Never Consider Treatment 3Health News:Survey Shows People With Varicose Veins Unaware of Health Risks; Most Never Consider Treatment 4Health News:Frontline Caregiver Coalition to Bush Administration: Stopping Pending $770 Million Medicare Cut Most Important 2008 Health Policy Issue 2
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),...
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
Medicine Products: